multiomic health limited
multiomic health limited Company Information
Company Number
13246608
Next Accounts
Dec 2025
Shareholders
vs asset holding llp
hoxton ventures iii l.p.
View AllGroup Structure
View All
Industry
Research and experimental development on biotechnology
Registered Address
epworth house 25 city road, london, EC1Y 1AA
Website
multiomic.healthmultiomic health limited Estimated Valuation
Pomanda estimates the enterprise value of MULTIOMIC HEALTH LIMITED at £1.2m based on a Turnover of £872.6k and 1.32x industry multiple (adjusted for size and gross margin).
multiomic health limited Estimated Valuation
Pomanda estimates the enterprise value of MULTIOMIC HEALTH LIMITED at £0 based on an EBITDA of £-896.1k and a 5.21x industry multiple (adjusted for size and gross margin).
multiomic health limited Estimated Valuation
Pomanda estimates the enterprise value of MULTIOMIC HEALTH LIMITED at £8.5m based on Net Assets of £4.7m and 1.79x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Multiomic Health Limited Overview
Multiomic Health Limited is a live company located in london, EC1Y 1AA with a Companies House number of 13246608. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in March 2021, it's largest shareholder is vs asset holding llp with a 18.2% stake. Multiomic Health Limited is a startup, small sized company, Pomanda has estimated its turnover at £872.6k with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Multiomic Health Limited Health Check
Pomanda's financial health check has awarded Multiomic Health Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 3 areas for improvement. Company Health Check FAQs
2 Strong
3 Regular
3 Weak
Size
annual sales of £872.6k, make it smaller than the average company (£3.6m)
- Multiomic Health Limited
£3.6m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Multiomic Health Limited
- - Industry AVG
Production
with a gross margin of 54.5%, this company has a comparable cost of product (54.5%)
- Multiomic Health Limited
54.5% - Industry AVG
Profitability
an operating margin of -103.1% make it less profitable than the average company (-7.2%)
- Multiomic Health Limited
-7.2% - Industry AVG
Employees
with 7 employees, this is below the industry average (46)
7 - Multiomic Health Limited
46 - Industry AVG
Pay Structure
on an average salary of £79.3k, the company has an equivalent pay structure (£79.3k)
- Multiomic Health Limited
£79.3k - Industry AVG
Efficiency
resulting in sales per employee of £124.7k, this is equally as efficient (£124.7k)
- Multiomic Health Limited
£124.7k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Multiomic Health Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Multiomic Health Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Multiomic Health Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 6632 weeks, this is more cash available to meet short term requirements (33 weeks)
6632 weeks - Multiomic Health Limited
33 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 0.6%, this is a lower level of debt than the average (51%)
0.6% - Multiomic Health Limited
51% - Industry AVG
MULTIOMIC HEALTH LIMITED financials
Multiomic Health Limited's latest turnover from March 2024 is estimated at £872.6 thousand and the company has net assets of £4.7 million. According to their latest financial statements, Multiomic Health Limited has 7 employees and maintains cash reserves of £3.6 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | |
|---|---|---|---|
| Turnover | |||
| Other Income Or Grants | |||
| Cost Of Sales | |||
| Gross Profit | |||
| Admin Expenses | |||
| Operating Profit | |||
| Interest Payable | |||
| Interest Receivable | |||
| Pre-Tax Profit | |||
| Tax | |||
| Profit After Tax | |||
| Dividends Paid | |||
| Retained Profit | |||
| Employee Costs | |||
| Number Of Employees | 7 | 4 | 6 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | |
|---|---|---|---|
| Tangible Assets | 7,312 | 6,640 | 9,990 |
| Intangible Assets | |||
| Investments & Other | |||
| Debtors (Due After 1 year) | |||
| Total Fixed Assets | 7,312 | 6,640 | 9,990 |
| Stock & work in progress | |||
| Trade Debtors | |||
| Group Debtors | 853,577 | ||
| Misc Debtors | 345,888 | 167,355 | 123,110 |
| Cash | 3,560,132 | 475,533 | 1,199,984 |
| misc current assets | |||
| total current assets | 4,759,597 | 642,888 | 1,323,094 |
| total assets | 4,766,909 | 649,528 | 1,333,084 |
| Bank overdraft | |||
| Bank loan | |||
| Trade Creditors | 1,447 | 1,879 | |
| Group/Directors Accounts | |||
| other short term finances | 1,852,826 | 1,852,826 | |
| hp & lease commitments | |||
| other current liabilities | 27,912 | 11,490 | 10,452 |
| total current liabilities | 27,912 | 1,865,763 | 1,865,157 |
| loans | |||
| hp & lease commitments | |||
| Accruals and Deferred Income | |||
| other liabilities | |||
| provisions | |||
| total long term liabilities | |||
| total liabilities | 27,912 | 1,865,763 | 1,865,157 |
| net assets | 4,738,997 | -1,216,235 | -532,073 |
| total shareholders funds | 4,738,997 | -1,216,235 | -532,073 |
| Mar 2024 | Mar 2023 | Mar 2022 | |
|---|---|---|---|
| Operating Activities | |||
| Operating Profit | |||
| Depreciation | 3,185 | 2,698 | |
| Amortisation | |||
| Tax | |||
| Stock | |||
| Debtors | 1,032,110 | 44,245 | 123,110 |
| Creditors | -1,447 | -432 | 1,879 |
| Accruals and Deferred Income | 16,422 | 1,038 | 10,452 |
| Deferred Taxes & Provisions | |||
| Cash flow from operations | |||
| Investing Activities | |||
| capital expenditure | |||
| Change in Investments | |||
| cash flow from investments | |||
| Financing Activities | |||
| Bank loans | |||
| Group/Directors Accounts | |||
| Other Short Term Loans | -1,852,826 | 1,852,826 | |
| Long term loans | |||
| Hire Purchase and Lease Commitments | |||
| other long term liabilities | |||
| share issue | |||
| interest | |||
| cash flow from financing | |||
| cash and cash equivalents | |||
| cash | 3,084,599 | -724,451 | 1,199,984 |
| overdraft | |||
| change in cash | 3,084,599 | -724,451 | 1,199,984 |
multiomic health limited Credit Report and Business Information
Multiomic Health Limited Competitor Analysis
Perform a competitor analysis for multiomic health limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in EC1Y area or any other competitors across 12 key performance metrics.
multiomic health limited Ownership
MULTIOMIC HEALTH LIMITED group structure
Multiomic Health Limited has no subsidiary companies.
Ultimate parent company
MULTIOMIC HEALTH LIMITED
13246608
multiomic health limited directors
Multiomic Health Limited currently has 4 directors. The longest serving directors include Mr Robert Thong (Mar 2021) and Mr Alasdair Thong (Mar 2021).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Robert Thong | England | 64 years | Mar 2021 | - | Director |
| Mr Alasdair Thong | United Kingdom | 35 years | Mar 2021 | - | Director |
| Mr Robert Kniaz | United Kingdom | 45 years | May 2023 | - | Director |
| Ms Charlotte Barttelot | United Kingdom | 36 years | Jan 2024 | - | Director |
P&L
March 2024turnover
872.6k
+148%
operating profit
-899.3k
0%
gross margin
54.5%
+1.16%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
4.7m
-4.9%
total assets
4.8m
+6.34%
cash
3.6m
+6.49%
net assets
Total assets minus all liabilities
Similar Companies
multiomic health limited company details
company number
13246608
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
incorporation date
March 2021
age
4
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
-
address
epworth house 25 city road, london, EC1Y 1AA
Bank
-
Legal Advisor
-
multiomic health limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to multiomic health limited.
multiomic health limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for MULTIOMIC HEALTH LIMITED. This can take several minutes, an email will notify you when this has completed.
multiomic health limited Companies House Filings - See Documents
| date | description | view/download |
|---|
